Connect with us

International

Meet The 2021 Manny Awards MedAdvocate Jury Members

The 32nd Annual Manny Awards, to be held virtually on April 22, 2021, features nearly 30 award categories. Sixteen creative award categories were voted on by leading creative talent throughout the healthcare communications industry via an online forum,…

Published

on

Meet The 2021 Manny Awards MedAdvocate Jury Members

The 32nd Annual Manny Awards, to be held virtually on April 22, 2021, features nearly 30 award categories. Sixteen creative award categories were voted on by leading creative talent throughout the healthcare communications industry via an online forum, with three finalists selected in each category. To help determine the winners, a second level of voting conducted by a carefully vetted jury of industry experts is being conducted by a select jury panel. The “MedAdvocate” jury, which is gathering virtually on March 18, consists of unbiased representatives who analyze the outstanding components of each finalist creative award campaign as part of an inspiring dialogue.

Presenting the 2021 Manny Awards MedAdvocate Jury Members …

 

Bruno Abner

Bruno Abner

EVP, Chief Creative Officer

McCann Health New Jersey
 
Now at McCann Health NJ as CCO, Bruno was the Creative Lead at McCann Health São Paulo and LATAM for 7 years. During this period, he was ranked top 5 most creative health offices across the globe according to Cannes. Graduated in art, since his first job Abner has worked exclusively for healthcare and wellness clients. With more than 80 brands in his background across all therapeutic areas, 17 years of experience and award-winning campaigns, Abner is raising the standards of the category globally.

 

Michael Austin

Michael Austin

EVP, Managing Director, Creative

Syneos Health Communications

Michael Austin knows that an advertising agency will save the world one day (soon). That’s because creativity is the only muscle that outmaneuvers the tyranny of the day. And doing that advances the way people experience the world. He has taken advantage of exercising creative license for 20 years as an award-winning creative writer/director and has now honed that muscle as a creative business leader. Today he works across Syneos Health Communications to embolden creative thinking and execution across advertising and PR.

As comfortable roaming around the clinical study report of a yet to launch molecule, as he is in executing a consumer website, as he is in strategizing around the c-suite table at a biotech company, Michael has earned the trust and friendship of his clients. He starts by trusting his own voice. A voice well-crafted by hard earned experience. He began his advertising career a century ago (in 1999) as an administrative assistant looking up medical references on the VIAGRA account.

Having joined the Syneos organization in 2015, Michael first led the creative department for PALIO, which in turn led to leading creative for the GSW NY and LA offices. The work he’s done throughout his career has garnered awards but those aren’t what he covets. He lives to give life to ideas. To birth them. To flight them. To encourage them.

Michael’s favorite question to would-be new clients is, “If you are smart enough to hire us, will you be brave enough to listen to us?”

 

Tracy Blackwell

Tracy Blackwell

Head of Creative, Cedar Knolls

Fingerpaint

Tracy Blackwell is an integral part of the founding leadership team at the Cedar Knolls, New Jersey office of Fingerpaint, where she heads an incredibly talented and growing creative group. Her guidance has helped the agency to double its revenue each year since it was established in 2018—an accomplishment that, believe it or not, is not new to Tracy. Prior to joining Fingerpaint, she spent more than 20 years at McCann, rising through the creative ranks and, ultimately, holding leadership positions not only in creative, but also in strategy and client service. There, she was part of the team that started and built McCann Echo from a start-up to a team of nearly 200.

Tracy is intuitive and candid by nature, which inspires truly connected teams whose work shines in the marketplace and wins awards along the way. Tracy has earned industry recognition herself, including being named both an HBA Rising Star and Luminary. She received her bachelor’s degree from George Washington University.

 

Mike Bonilla

Mike Bonilla

Executive Creative Director

Klick Health

A seasoned Executive Creative Director with more than 16 years of experience in healthcare advertising, Mike has worked on everything from PSAs, to high science brands, to patient initiatives across a wide range of therapeutic areas, including mental health, women’s health, GI health, respiratory, neurology, and oncology.

His creative work has been published in industry shows, such as Cannes Lions, One Show, Med Ad News, MM&M, Graphis, The Creative Floor, IPA, and LIA. Michael has previously worked at McCann Health, GSW, and FCB, and led the vision for his creative teams across HCP, DTC, US and Global campaigns.

Continuously learning about new disease states and the unmet needs of both patients and HCPs keeps Mike on his toes. Over the last two years, Mike has led multiple campaign launches — from an HCP-focused unbranded campaign for eosiniphilic esophagitis, to a biologic launch for asthma, to a US and Global launch of an innovative migraine medicine, and a US launch of a rescue medication device for severe hypoglycemia.

Mike’s commitment to strong communication and craft has been recognized in the industry, having previously served on the MM&M jury as well as chairing the Pharma jury at the Global Awards.

Mike has also done many rewarding passion projects with clients, such as Movember, the National Organization for Women, and the Boomer Esiason Foundation.

 

Mike Brune


Mike Brune
 
Executive Creative Director
 
Ogilvy Health
 

 

Current Position

Mike embraces his role as Creative Director bringing a focus that goes beyond his own personal standard for brand-building, to include fostering an environment that empowers others on the team to flourish. An inspired, “all-in” team is the best way to create work that excites clients while moving people to act and markets to shift. Achieving those objectives while building team camaraderie throughout the process are of equal importance to Mike.

Experience

Mike has helped lead the creative charge for a wide range of Ogilvy Health clients for 20+ years. His body of work includes numerous market-shaping campaigns, new product launches and revitalized branding for products ranging from oncology and hospital-based anti-infectives to skin care and mouth rinse. Throughout his nearly 25 years in pharmaceutical marketing, Mike’s passion for crystallizing a brand promise in a way that elicits behavior-changing responses has helped his clients build powerful, enduring brands.

About Mike

Mike and his wife, Anna live in Flemington, NJ. Mike is a life-long fan of the NY Mets, Vikings, NY Rangers…and happily accepts all the sympathy that accompanies those choices.  He ensures contact with friends through weekends on the golf course during the day; and works on his “cultural side” through movies, museums, or theater at night. 

 

Eric Delnicki

Eric Delnicki

SVP, Creative Director

Peregrine Market Access

Saratoga Springs, NY

Simply put, Eric Delnicki designs communications that get noticed and have impact. His facility for delivering complex information in accessible, understandable visible executions has driven his success in a wide range of communication fields, especially healthcare. He has developed materials for every phase of the product life-cycle, from pre-launch market conditioning and disease awareness through complete launch suites, label expansions, patient retention, and sales training. He’s worked in esoteric specialties such as HIV, oncology, infectious diseases, pain management, and neurology. His work has won regional, national, and international awards. His vast pharmaceutical industry experience encompasses high-science specialties with a focus in market access communications.

EXPERIENCE: Delnicki was with Syneos Health for more than 19 years, including 4 years on the leadership team of the Market Access consultancy. He has also worked in HCP and consumer advertising for a wide range of brands and disease states for patients, healthcare providers, and payers. Previously, he supervised catalog creation and national advertising campaigns for the Orvis Company, and worked at consumer and B2B agencies. Delnicki has extensive experience in the recruitment and management of a wide range of creative vendors, including photographers, freelance artists, and illustrators.

 

Josh Eastman

Josh Eastman 

Group Creative Director 

Grey Group

16 years ago, Josh moved to NYC with no money, no contacts, and no idea what healthcare advertising was. With a little bit of hustle, A LOT of luck, and the remarkable patience of generous mentors, he started his journey into the world of HCPs, patients, and important safety information. Along the way Eastman has won a couple handfuls of industry awards, preached the power of balance and patience, and mastered the art of the mighty, magnanimous and mischievous serial comma.

 

Sam Glasgow

Samantha Glasgow

Creative Director  

Purohit Navigation

Sam is the Creative Director at healthcare marketing and strategy firm, Purohit Navigation. She utilizes her industrial design background and unstoppable drive to create breakthrough work. She guides her team as they work with the copy group, ensuring that every project not only achieves its strategic objectives, but pushes creative boundaries with unexpected solutions Hailing from multi-cultural Australasia, Sam’s strong appreciation for cultural diversity broadens her insp

 

Diane Iler-Smith

Diane Iler-Smith

Chief Creative Officer

Biolumina

Diane leads the creative department at Biolumina, a healthcare advertising agency currently focused in oncology. Overseeing a team of over 70 art directors and copywriters, she is responsible for ensuring the creative quality and integrity of the agency’s work. Diane has a Masters degree in Biology and started her career in advertising as a copywriter. Diane is married to her college lab partner and is the proud mother of 2 millennials. She enjoys discovering new biodynamic wines and prior to the pandemic, listening to podcasts on her drive into the NYC, and spending time with family and friends.

 

Marcus “Kawa” Kawamura

Marcus “Kawa” Kawamura

Executive Creative Director

AREA 23 

Marcus “Kawa” Kawamura joined AREA 23, an FCB Health Network Company, in December 2020 as executive creative director, reporting to chief creative officer Tim Hawkey. Kawamura develops groundbreaking ideas that help clients reach their audiences in new and innovative ways.

An award-winning creative with 20 years of experience in art direction, design and more, Kawamura has worked at top creative agencies such as Crispin Porter Bogusky, The Community, AlmapBBDO, Africa, DM9DDB and Leo Burnett. His creative portfolio spans global consumer brands, such as Volkswagen, Infiniti, Verizon, Pepsi, AB Inbev, Marriott Hotels, Visa, Havaianas, Pedigree, Letgo and Fifa, among others.

 

Felipe Munhoz

Felipe Munhoz

EVP, Group Creative Director

CDM New York

Felipe is a passionate EVP, Group Creative Director, with over 16 years of experience. He has developed campaigns for the most important clients in the world and being recognized with most of the awards, including Manny’s, Clio Health, Cannes, D&AD and One Show. In 2019 he was ranked by Luerzer’s Archive Magazine #1 Art Director in US.

With an under-graduation on Advertising and graduation on Strategic Design, he joined CDM in 2020, and since then he’s been responsible for raising the bar of the agency’s creative work, developing campaigns that combine a unique strategic approach with a stunning art direction.

Prior experience includes leading one of the creative teams in TBWA Brazil to get Kimberly Clark’s first Gold Lion in Cannes and creative director at Area 23, collecting dozens of awards. Through all his career, he had clients such Lilly, Bayer and GSK, combining experience in consumer, pharma and different medias (film, print, digital and activations). 

Felipe is also passionate about photography. But over the last 3 years he has shooting the same thing over and over again: his 10-months old baby girl and 3-years-old boy.

 

Susan Perlbachs


Susan Perlbachs
 
Chief Creative Officer
 
Intouch Group

Award-winning executive Susan Perlbachs is chief creative officer (CCO) at Intouch Group. As CCO, Perlbachs is responsible for creative leadership across all Intouch Group affiliates, locations and clients. Announced as CCO of the privately held full-service agency network on Aug. 6, 2020, Perlbachs is based in Intouch’s New York office.

Perlbachs arrived at Intouch with nearly 20 years of experience with other renowned healthcare agencies, including high-level positions at GSW and Grey Healthcare, driving major campaigns for U.S. and global brands for professional and consumer audiences, including over-the-counter, oncology, nephrology and neurology. Most recently before joining Intouch, she served as EVP, Group Creative Director at FCB Health. Honors and accolades include being named one of PharmaVoice’s Top 100 Most Inspiring People, speaking at Cannes Lions Health and serving as a Clio judge. She also was named an HBA Rising Star.

 

Gary Scheiner


Gary Scheiner
 
Executive Vice President, Executive Creative Director    
 
CDM Princeton
 

Gary Scheiner has had a pretty fulfilling career so far. His first commercial ran during the Super Bowl. He launched several new car brands for GM, a wine brand for Kraft, and The Michael J. Fox Foundation hand-in-hand with Michael J. Fox. He’s worked with A-list celebrities, Grammy-winning musicians and Academy Award-winning directors. He even recorded a Beatles song in Abbey Road Studios, using the same Hammond B3 organ that Paul McCartney played on the original track. (That was cool!) But of all the amazing things he’s been a part of, he’s most excited about where he is right now­ – in healthcare, with all its innovation and game-changing, life-changing products and services. 

For the better part of the past 30 years, Gary has had one foot in healthcare marketing and one foot in general advertising, and that dual perspective has kept his work fresh and unexpected. The proof is in the results. He built 3 successful consumer healthcare practices at 3 different non-healthcare agencies. His campaigns for Schering-Plough and Allergan both became cultural icons that lit up social media and late-night talk shows. In fact, Adweek listed his Viberzi campaign #26 on the top 50 most talked about campaigns of 2016. (It was the only healthcare campaign on the list.)

Gary’s work has been honored with hundreds of creative and effectiveness awards – everything from Cannes Lions to Clios, Kellys, ADDYs, Globals, MM&Ms, Manny’s, Globals, NY Festival (Best of Show), DMA ECHO Awards (Best of Show – twice), Webbys, OMMAs, and more. He regularly sits on many of the above award show juries. In 2018, Gary was inducted into the DTC Perspectives Hall of Fame for a career of creating differentiating, motivating consumer healthcare marketing.

Today, Gary calls CDM Princeton home, where as EVP, Executive Creative Director, he oversees the creative direction for the agency’s impressive portfolio of lifechanging brands. And he couldn’t be more excited.

 

James Talerico

James Talerico

President & Executive Creative Director

Heartbeat

Growing up near Scranton Pennsylvania, James spent a childhood in his grandfather’s bar, serving pony bottles of Rolling Rock to retired coal miners while memorizing verb declensions for the next day’s Latin class. He’s been seeking out and creating such strange juxtapositions ever since.

As President & Executive Creative Director for Heartbeat – the Agency for Healthcare Challenger Brands – James has launched ambitious creative campaigns, unafraid of emotion, rich in craft and tailored to inspire action, for clients such as Genentech and Pfizer, Applied Therapeutics and Agile Therapeutics. With his clients, his teams have hoisted more than 200 creative advertising awards during the last ten years, from Pencils to MANNYs, Webbies to EMMYs.

James started his career in advertising as a founding partner and creative leader of thoughtbubble productions in 1997, a creative agency on the front lines of the digital revolution. Thoughtbubble’s ground-breaking initiatives were featured in the New York Times, Newsweek, Ad Age and AdWeek as harbingers of the next generation of advertising content.

His subsequent path to healthcare carved through sectors as diverse as publishing and CPG, QSR and professional sports. Along the way James picked up a healthy skepticism of the latest thing and a deep commitment to advancing good health through creative wonder and hard work.

Sometimes found sitting on a piece of fiberglass off the coast of New Jersey, James is madly in love with two glorious women: his wife, Shawn, and daughter, Hallelujah. His favorite color is white.

 

About the 2021 Manny Awards and MedAdvocate Jury Members

Med Ad News honors the best in healthcare communications at the 32nd Annual Manny Awards, to be held virtually on April 22nd, 2021.

For more than thirty years, the Manny Awards have paid tribute to the creative work of agencies serving the healthcare market, their people and their contributions to the industry. Each year at this gala awards ceremony, Med Ad News and agency professionals come together to acknowledge those making significant contributions to, and celebrate creative excellence in, healthcare communications. On this special evening, more than 1,000 industry peers will join Med Ad News in honoring winners in a range of award categories.

Launched as part of the 2016 Med Ad News Manny Awards, a second level of voting is conducted by a carefully vetted jury of industry experts. Finalists in each category, determined by the initial online voting process, will be reviewed in detail by the judging panel. The “MedAdvocate” panel consists of unbiased representatives who analyze the outstanding components of each finalist creative award campaign as part of an inspiring dialogue.

This process is repeated for each category finalist for every creative category. Following the panel’s discussion, the Manny Awards MedAdvocate Jury is asked to cast their blind ballots to determine the winning campaigns.

Register for the virtual 32nd Annual Manny Awards on Thursday, April 22nd, 2021.

 

Read More

Continue Reading

International

‘Excess Mortality Skyrocketed’: Tucker Carlson and Dr. Pierre Kory Unpack ‘Criminal’ COVID Response

‘Excess Mortality Skyrocketed’: Tucker Carlson and Dr. Pierre Kory Unpack ‘Criminal’ COVID Response

As the global pandemic unfolded, government-funded…

Published

on

'Excess Mortality Skyrocketed': Tucker Carlson and Dr. Pierre Kory Unpack 'Criminal' COVID Response

As the global pandemic unfolded, government-funded experimental vaccines were hastily developed for a virus which primarily killed the old and fat (and those with other obvious comorbidities), and an aggressive, global campaign to coerce billions into injecting them ensued.

Then there were the lockdowns - with some countries (New Zealand, for example) building internment camps for those who tested positive for Covid-19, and others such as China welding entire apartment buildings shut to trap people inside.

It was an egregious and unnecessary response to a virus that, while highly virulent, was survivable by the vast majority of the general population.

Oh, and the vaccines, which governments are still pushing, didn't work as advertised to the point where health officials changed the definition of "vaccine" multiple times.

Tucker Carlson recently sat down with Dr. Pierre Kory, a critical care specialist and vocal critic of vaccines. The two had a wide-ranging discussion, which included vaccine safety and efficacy, excess mortality, demographic impacts of the virus, big pharma, and the professional price Kory has paid for speaking out.

Keep reading below, or if you have roughly 50 minutes, watch it in its entirety for free on X:

"Do we have any real sense of what the cost, the physical cost to the country and world has been of those vaccines?" Carlson asked, kicking off the interview.

"I do think we have some understanding of the cost. I mean, I think, you know, you're aware of the work of of Ed Dowd, who's put together a team and looked, analytically at a lot of the epidemiologic data," Kory replied. "I mean, time with that vaccination rollout is when all of the numbers started going sideways, the excess mortality started to skyrocket."

When asked "what kind of death toll are we looking at?", Kory responded "...in 2023 alone, in the first nine months, we had what's called an excess mortality of 158,000 Americans," adding "But this is in 2023. I mean, we've  had Omicron now for two years, which is a mild variant. Not that many go to the hospital."

'Safe and Effective'

Tucker also asked Kory why the people who claimed the vaccine were "safe and effective" aren't being held criminally liable for abetting the "killing of all these Americans," to which Kory replied: "It’s my kind of belief, looking back, that [safe and effective] was a predetermined conclusion. There was no data to support that, but it was agreed upon that it would be presented as safe and effective."

Carlson and Kory then discussed the different segments of the population that experienced vaccine side effects, with Kory noting an "explosion in dying in the youngest and healthiest sectors of society," adding "And why did the employed fare far worse than those that weren't? And this particularly white collar, white collar, more than gray collar, more than blue collar."

Kory also said that Big Pharma is 'terrified' of Vitamin D because it "threatens the disease model." As journalist The Vigilant Fox notes on X, "Vitamin D showed about a 60% effectiveness against the incidence of COVID-19 in randomized control trials," and "showed about 40-50% effectiveness in reducing the incidence of COVID-19 in observational studies."

Professional costs

Kory - while risking professional suicide by speaking out, has undoubtedly helped save countless lives by advocating for alternate treatments such as Ivermectin.

Kory shared his own experiences of job loss and censorship, highlighting the challenges of advocating for a more nuanced understanding of vaccine safety in an environment often resistant to dissenting voices.

"I wrote a book called The War on Ivermectin and the the genesis of that book," he said, adding "Not only is my expertise on Ivermectin and my vast clinical experience, but and I tell the story before, but I got an email, during this journey from a guy named William B Grant, who's a professor out in California, and he wrote to me this email just one day, my life was going totally sideways because our protocols focused on Ivermectin. I was using a lot in my practice, as were tens of thousands of doctors around the world, to really good benefits. And I was getting attacked, hit jobs in the media, and he wrote me this email on and he said, Dear Dr. Kory, what they're doing to Ivermectin, they've been doing to vitamin D for decades..."

"And it's got five tactics. And these are the five tactics that all industries employ when science emerges, that's inconvenient to their interests. And so I'm just going to give you an example. Ivermectin science was extremely inconvenient to the interests of the pharmaceutical industrial complex. I mean, it threatened the vaccine campaign. It threatened vaccine hesitancy, which was public enemy number one. We know that, that everything, all the propaganda censorship was literally going after something called vaccine hesitancy."

Money makes the world go 'round

Carlson then hit on perhaps the most devious aspect of the relationship between drug companies and the medical establishment, and how special interests completely taint science to the point where public distrust of institutions has spiked in recent years.

"I think all of it starts at the level the medical journals," said Kory. "Because once you have something established in the medical journals as a, let's say, a proven fact or a generally accepted consensus, consensus comes out of the journals."

"I have dozens of rejection letters from investigators around the world who did good trials on ivermectin, tried to publish it. No thank you, no thank you, no thank you. And then the ones that do get in all purportedly prove that ivermectin didn't work," Kory continued.

"So and then when you look at the ones that actually got in and this is where like probably my biggest estrangement and why I don't recognize science and don't trust it anymore, is the trials that flew to publication in the top journals in the world were so brazenly manipulated and corrupted in the design and conduct in, many of us wrote about it. But they flew to publication, and then every time they were published, you saw these huge PR campaigns in the media. New York Times, Boston Globe, L.A. times, ivermectin doesn't work. Latest high quality, rigorous study says. I'm sitting here in my office watching these lies just ripple throughout the media sphere based on fraudulent studies published in the top journals. And that's that's that has changed. Now that's why I say I'm estranged and I don't know what to trust anymore."

Vaccine Injuries

Carlson asked Kory about his clinical experience with vaccine injuries.

"So how this is how I divide, this is just kind of my perception of vaccine injury is that when I use the term vaccine injury, I'm usually referring to what I call a single organ problem, like pericarditis, myocarditis, stroke, something like that. An autoimmune disease," he replied.

"What I specialize in my practice, is I treat patients with what we call a long Covid long vaxx. It's the same disease, just different triggers, right? One is triggered by Covid, the other one is triggered by the spike protein from the vaccine. Much more common is long vax. The only real differences between the two conditions is that the vaccinated are, on average, sicker and more disabled than the long Covids, with some pretty prominent exceptions to that."

Watch the entire interview above, and you can support Tucker Carlson's endeavors by joining the Tucker Carlson Network here...

Tyler Durden Thu, 03/14/2024 - 16:20

Read More

Continue Reading

International

Delta Air Lines adds a new route travelers have been asking for

The new Delta seasonal flight to the popular destination will run daily on a Boeing 767-300.

Published

on

Those who have tried to book a flight from North America to Europe in the summer of 2023 know just how high travel demand to the continent has spiked.

At 2.93 billion, visitors to the countries making up the European Union had finally reached pre-pandemic levels last year while North Americans in particular were booking trips to both large metropolises such as Paris and Milan as well as smaller cities growing increasingly popular among tourists.

Related: A popular European city is introducing the highest 'tourist tax' yet

As a result, U.S.-based airlines have been re-evaluating their networks to add more direct routes to smaller European destinations that most travelers would have previously needed to reach by train or transfer flight with a local airline.

The new flight will take place on a Boeing 767-300.

Shutterstock

Delta Air Lines: ‘Glad to offer customers increased choice…’

By the end of March, Delta Air Lines  (DAL)  will be restarting its route between New York’s JFK and Marco Polo International Airport in Venice as well as launching two new flights to Venice from Atlanta. One will start running this month while the other will be added during peak demand in the summer.

More Travel:

“As one of the most beautiful cities in the world, Venice is hugely popular with U.S. travelers, and our flights bring valuable tourism and trade opportunities to the city and the region as well as unrivalled opportunities for Venetians looking to explore destinations across the Americas,” Delta’s SVP for Europe Matteo Curcio said in a statement. “We’re glad to offer customers increased choice this summer with flights from New York and additional service from Atlanta.”

The JFK-Venice flight will run on a Boeing 767-300  (BA)  and have 216 seats including higher classes such as Delta One, Delta Premium Select and Delta Comfort Plus.

Delta offers these features on the new flight

Both the New York and Atlanta flights are seasonal routes that will be pulled out of service in October. Both will run daily while the first route will depart New York at 8:55 p.m. and arrive in Venice at 10:15 a.m. local time on the way there, while leaving Venice at 12:15 p.m. to arrive at JFK at 5:05 p.m. on the way back.

According to Delta, this will bring its service to 17 flights from different U.S. cities to Venice during the peak summer period. As with most Delta flights at this point, passengers in all fare classes will have access to free Wi-Fi during the flight.

Those flying in Delta’s highest class or with access through airline status or a credit card will also be able to use the new Delta lounge that is part of the airline’s $12 billion terminal renovation and is slated to open to travelers in the coming months. The space will take up more than 40,000 square feet and have an outdoor terrace.

“Delta One customers can stretch out in a lie-flat seat and enjoy premium amenities like plush bedding made from recycled plastic bottles, more beverage options, and a seasonal chef-curated four-course meal,” Delta said of the new route. “[…] All customers can enjoy a wide selection of in-flight entertainment options and stay connected with Wi-Fi and enjoy free mobile messaging.”

Read More

Continue Reading

International

Shakira’s net worth

After 12 albums, a tax evasion case, and now a towering bronze idol sculpted in her image, how much is Shakira worth more than 4 decades into her care…

Published

on

Shakira’s considerable net worth is no surprise, given her massive popularity in Latin America, the U.S., and elsewhere. 

In fact, the belly-dancing contralto queen is the second-wealthiest Latin-America-born pop singer of all time after Gloria Estefan. (Interestingly, Estefan actually helped a young Shakira translate her breakout album “Laundry Service” into English, hugely propelling her stateside success.)

Since releasing her first record at age 13, Shakira has spent decades recording albums in both Spanish and English and performing all over the world. Over the course of her 40+ year career, she helped thrust Latin pop music into the American mainstream, paving the way for the subsequent success of massively popular modern acts like Karol G and Bad Bunny.

In late 2023, a 21-foot-tall bronze sculpture of Shakira, the barefoot belly dancer of Barranquilla, was unveiled at the city's waterfront. The statue was commissioned by the city's former mayor and other leadership.

Photo by STR/AFP via Getty Images

In December 2023, a 21-foot-tall beachside bronze statue of the “Hips Don’t Lie” singer was unveiled in her Colombian hometown of Barranquilla, making her a permanent fixture in the city’s skyline and cementing her legacy as one of Latin America’s most influential entertainers.

After 12 albums, a plethora of film and television appearances, a highly publicized tax evasion case, and now a towering bronze idol sculpted in her image, how much is Shakira worth? What does her income look like? And how does she spend her money?

Related: Dwayne 'The Rock' Johnson's net worth: How the new TKO Board Member built his wealth from $7

How much is Shakira worth?

In late 2023, Spanish sports and lifestyle publication Marca reported Shakira’s net worth at $400 million, citing Forbes as the figure’s source (although Forbes’ profile page for Shakira does not list a net worth — and didn’t when that article was published).

Most other sources list the singer’s wealth at an estimated $300 million, and almost all of these point to Celebrity Net Worth — a popular but dubious celebrity wealth estimation site — as the source for the figure.

A $300 million net worth would make Shakira the third-richest Latina pop star after Gloria Estefan ($500 million) and Jennifer Lopez ($400 million), and the second-richest Latin-America-born pop singer after Estefan (JLo is Puerto Rican but was born in New York).

Shakira’s income: How much does she make annually?

Entertainers like Shakira don’t have predictable paychecks like ordinary salaried professionals. Instead, annual take-home earnings vary quite a bit depending on each year’s album sales, royalties, film and television appearances, streaming revenue, and other sources of income. As one might expect, Shakira’s earnings have fluctuated quite a bit over the years.

From June 2018 to June 2019, for instance, Shakira was the 10th highest-earning female musician, grossing $35 million, according to Forbes. This wasn’t her first time gracing the top 10, though — back in 2012, she also landed the #10 spot, bringing in $20 million, according to Billboard.

In 2023, Billboard listed Shakira as the 16th-highest-grossing Latin artist of all time.

Shakira performed alongside producer Bizarrap during the 2023 Latin Grammy Awards Gala in Seville.

Photo By Maria Jose Lopez/Europa Press via Getty Images

How much does Shakira make from her concerts and tours?

A large part of Shakira’s wealth comes from her world tours, during which she sometimes sells out massive stadiums and arenas full of passionate fans eager to see her dance and sing live.

According to a 2020 report by Pollstar, she sold over 2.7 million tickets across 190 shows that grossed over $189 million between 2000 and 2020. This landed her the 19th spot on a list of female musicians ranked by touring revenue during that period. In 2023, Billboard reported a more modest touring revenue figure of $108.1 million across 120 shows.

In 2003, Shakira reportedly generated over $4 million from a single show on Valentine’s Day at Foro Sol in Mexico City. 15 years later, in 2018, Shakira grossed around $76.5 million from her El Dorado World Tour, according to Touring Data.

Related: RuPaul's net worth: Everything to know about the cultural icon and force behind 'Drag Race'

How much has Shakira made from her album sales?

According to a 2023 profile in Variety, Shakira has sold over 100 million records throughout her career. “Laundry Service,” the pop icon’s fifth studio album, was her most successful, selling over 13 million copies worldwide, according to TheRichest.

Exactly how much money Shakira has taken home from her album sales is unclear, but in 2008, it was widely reported that she signed a 10-year contract with LiveNation to the tune of between $70 and $100 million to release her subsequent albums and manage her tours.

Shakira and JLo co-headlined the 2020 Super Bowl Halftime Show in Florida.

Photo by Kevin Winter/Getty Images)

How much did Shakira make from her Super Bowl and World Cup performances?

Shakira co-wrote one of her biggest hits, “Waka Waka (This Time for Africa),” after FIFA selected her to create the official anthem for the 2010 World Cup in South Africa. She performed the song, along with several of her existing fan-favorite tracks, during the event’s opening ceremonies. TheThings reported in 2023 that the song generated $1.4 million in revenue, citing Popnable for the figure.

A decade later, 2020’s Superbowl halftime show featured Shakira and Jennifer Lopez as co-headliners with guest performances by Bad Bunny and J Balvin. The 14-minute performance was widely praised as a high-energy celebration of Latin music and dance, but as is typical for Super Bowl shows, neither Shakira nor JLo was compensated beyond expenses and production costs.

The exposure value that comes with performing in the Super Bowl Halftime Show, though, is significant. It is typically the most-watched television event in the U.S. each year, and in 2020, a 30-second Super Bowl ad spot cost between $5 and $6 million.

How much did Shakira make as a coach on “The Voice?”

Shakira served as a team coach on the popular singing competition program “The Voice” during the show’s fourth and sixth seasons. On the show, celebrity musicians coach up-and-coming amateurs in a team-based competition that eventually results in a single winner. In 2012, The Hollywood Reporter wrote that Shakira’s salary as a coach on “The Voice” was $12 million.

Related: John Cena's net worth: The wrestler-turned-actor's investments, businesses, and more

How does Shakira spend her money?

Shakira doesn’t just make a lot of money — she spends it, too. Like many wealthy entertainers, she’s purchased her share of luxuries, but Barranquilla’s barefoot belly dancer is also a prolific philanthropist, having donated tens of millions to charitable causes throughout her career.

Private island

Back in 2006, she teamed up with Roger Waters of Pink Floyd fame and Spanish singer Alejandro Sanz to purchase Bonds Cay, a 550-acre island in the Bahamas, which was listed for $16 million at the time.

Along with her two partners in the purchase, Shakira planned to develop the island to feature housing, hotels, and an artists’ retreat designed to host a revolving cast of artists-in-residence. This plan didn’t come to fruition, though, and as of this article’s last update, the island was once again for sale on Vladi Private Islands.

Real estate and vehicles

Like most wealthy celebs, Shakira’s portfolio of high-end playthings also features an array of luxury properties and vehicles, including a home in Barcelona, a villa in Cyprus, a Miami mansion, and a rotating cast of Mercedes-Benz vehicles.

Philanthropy and charity

Shakira doesn’t just spend her massive wealth on herself; the “Queen of Latin Music” is also a dedicated philanthropist and regularly donates portions of her earnings to the Fundación Pies Descalzos, or “Barefoot Foundation,” a charity she founded in 1997 to “improve the education and social development of children in Colombia, which has suffered decades of conflict.” The foundation focuses on providing meals for children and building and improving educational infrastructure in Shakira’s hometown of Barranquilla as well as four other Colombian communities.

In addition to her efforts with the Fundación Pies Descalzos, Shakira has made a number of other notable donations over the years. In 2007, she diverted a whopping $40 million of her wealth to help rebuild community infrastructure in Peru and Nicaragua in the wake of a devastating 8.0 magnitude earthquake. Later, during the COVID-19 pandemic in 2020, Shakira donated a large supply of N95 masks for healthcare workers and ventilators for hospital patients to her hometown of Barranquilla.

Back in 2010, the UN honored Shakira with a medal to recognize her dedication to social justice, at which time the Director General of the International Labour Organization described her as a “true ambassador for children and young people.”

On November 20, 2023 (which was supposed to be her first day of trial), Shakira reached a deal with the prosecution that resulted in a three-year suspended sentence and around $8 million in fines.

Photo by Adria Puig/Anadolu via Getty Images

Shakira’s tax fraud scandal: How much did she pay?

In 2018, prosecutors in Spain initiated a tax evasion case against Shakira, alleging she lived primarily in Spain from 2012 to 2014 and therefore failed to pay around $14.4 million in taxes to the Spanish government. Spanish law requires anyone who is “domiciled” (i.e., living primarily) in Spain for more than half of the year to pay income taxes.

During the period in question, Shakira listed the Bahamas as her primary residence but did spend some time in Spain, as she was dating Gerard Piqué, a professional footballer and Spanish citizen. The couple’s first son, Milan, was also born in Barcelona during this period. 

Shakira maintained that she spent far fewer than 183 days per year in Spain during each of the years in question. In an interview with Elle Magazine, the pop star opined that “Spanish tax authorities saw that I was dating a Spanish citizen and started to salivate. It's clear they wanted to go after that money no matter what."

Prosecutors in the case sought a fine of almost $26 million and a possible eight-year prison stint, but in November of 2023, Shakira took a deal to close the case, accepting a fine of around $8 million and a three-year suspended sentence to avoid going to trial. In reference to her decision to take the deal, Shakira stated, "While I was determined to defend my innocence in a trial that my lawyers were confident would have ruled in my favour [had the trial proceeded], I have made the decision to finally resolve this matter with the best interest of my kids at heart who do not want to see their mom sacrifice her personal well-being in this fight."

How much did the Shakira statue in Barranquilla cost?

In late 2023, a 21-foot-tall bronze likeness of Shakira was unveiled on a waterfront promenade in Barranquilla. The city’s then-mayor, Jaime Pumarejo, commissioned Colombian sculptor Yino Márquez to create the statue of the city’s treasured pop icon, along with a sculpture of the city’s coat of arms.

According to the New York Times, the two sculptures cost the city the equivalent of around $180,000. A plaque at the statue’s base reads, “A heart that composes, hips that don’t lie, an unmatched talent, a voice that moves the masses and bare feet that march for the good of children and humanity.” 

Related: Taylor Swift net worth: The most successful entertainer joins the billionaire's club

Read More

Continue Reading

Trending